PMC:7652766 / 87296-87452
Annnotations
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T427 | 0-156 | Sentence | denotes | In this study, we selected the following most promising treatment options: lopinavir/ritonavir, arbidol, ribavirin, remdesivir, favipiravir, and type I IFN. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3163 | 75-94 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
| 3164 | 96-103 | Chemical | denotes | arbidol | MESH:C086979 |
| 3165 | 105-114 | Chemical | denotes | ribavirin | MESH:D012254 |
| 3166 | 116-126 | Chemical | denotes | remdesivir | MESH:C000606551 |
| 3167 | 128-139 | Chemical | denotes | favipiravir | MESH:C462182 |